Who We Are

3Scan is turning tissue biology and histopathology into data science, giving researchers the insights they need to break new ground.

A one-stop shop for digital and computational pathology, 3Scan’s KESM produces digital 3D tissue models with micron-scale resolution at 400 times the throughput of traditional microscopes.

3Scan’s data platform enables quantitative image analysis of diseases like cancer, Parkinson’s, Alzheimer’s, and Huntington’s, opening up the potential for new diagnostic and therapeutic solutions.

Founded by Todd Huffman, Megan Klimen, Matthew Goodman, and Cody Daniel in San Francisco in 2011, 3Scan’s team of engineers, biologists and data-scientists is expanding its work into a suite of digital tools that will allow instant identification and classification of histopathologic features and tissue structures.

3Scan FAQ

Load More

Milestones

2018 – 3Scan and Prellis join to 3D print tissue

2018 – NIH Grant

2016 – Series B closes ($14M)

2015 – Series A closes ($8M)

2012 – Breakout Labs ($350K)

2012 – Commercial system built

2011 – DARPA becomes 1st customer ($30K)

2011 – Founding investment ($150K)

2010 – 3Scan spins-off Texas A&M Brain Network

2008 – Patent (US 6,744,572) is licensed to 3Scan

2004 – NSF & NIH grant ($1.6M) funds invention of the KESM